DSM-FIRMENICH AG (ZX6.DE) Fundamental Analysis & Valuation

FRA:ZX6 • CH1216478797

Current stock price

61.22 EUR
+0.32 (+0.53%)
Last:

This ZX6.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. ZX6.DE Profitability Analysis

1.1 Basic Checks

  • ZX6 had negative earnings in the past year.
  • ZX6 had a positive operating cash flow in the past year.
  • Of the past 5 years ZX6 4 years were profitable.
  • ZX6 had a positive operating cash flow in 4 of the past 5 years.
ZX6.DE Yearly Net Income VS EBIT VS OCF VS FCFZX6.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 0 1B -1B 2B

1.2 Ratios

  • ZX6's Return On Assets of -3.34% is on the low side compared to the rest of the industry. ZX6 is outperformed by 66.67% of its industry peers.
  • ZX6 has a worse Return On Equity (-5.06%) than 65.22% of its industry peers.
  • With a Return On Invested Capital value of 1.67%, ZX6 is not doing good in the industry: 63.77% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -3.34%
ROE -5.06%
ROIC 1.67%
ROA(3y)1.09%
ROA(5y)N/A
ROE(3y)1.5%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZX6.DE Yearly ROA, ROE, ROICZX6.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 0 5 -5 10 15

1.3 Margins

  • ZX6 has a Operating Margin (7.39%) which is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of ZX6 has declined.
  • ZX6 has a Gross Margin of 39.07%. This is comparable to the rest of the industry: ZX6 outperforms 56.52% of its industry peers.
  • ZX6's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.39%
PM (TTM) N/A
GM 39.07%
OM growth 3Y-2.63%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.82%
GM growth 5YN/A
ZX6.DE Yearly Profit, Operating, Gross MarginsZX6.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 0 10 -10 20 30

5

2. ZX6.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ZX6 is destroying value.
  • ZX6 has less shares outstanding than it did 1 year ago.
  • The debt/assets ratio for ZX6 is higher compared to a year ago.
ZX6.DE Yearly Shares OutstandingZX6.DE Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 50M 100M 150M 200M 250M
ZX6.DE Yearly Total Debt VS Total AssetsZX6.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • ZX6 has an Altman-Z score of 1.88. This is not the best score and indicates that ZX6 is in the grey zone with still only limited risk for bankruptcy at the moment.
  • ZX6's Altman-Z score of 1.88 is on the low side compared to the rest of the industry. ZX6 is outperformed by 62.32% of its industry peers.
  • ZX6 has a debt to FCF ratio of 7.12. This is a slightly negative value and a sign of low solvency as ZX6 would need 7.12 years to pay back of all of its debts.
  • ZX6's Debt to FCF ratio of 7.12 is in line compared to the rest of the industry. ZX6 outperforms 59.42% of its industry peers.
  • ZX6 has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
  • ZX6's Debt to Equity ratio of 0.24 is fine compared to the rest of the industry. ZX6 outperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 7.12
Altman-Z 1.88
ROIC/WACC0.42
WACC3.96%
ZX6.DE Yearly LT Debt VS Equity VS FCFZX6.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 5B 10B 15B 20B

2.3 Liquidity

  • A Current Ratio of 2.69 indicates that ZX6 has no problem at all paying its short term obligations.
  • ZX6's Current ratio of 2.69 is amongst the best of the industry. ZX6 outperforms 84.06% of its industry peers.
  • ZX6 has a Quick Ratio of 1.74. This is a normal value and indicates that ZX6 is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.74, ZX6 belongs to the top of the industry, outperforming 81.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.69
Quick Ratio 1.74
ZX6.DE Yearly Current Assets VS Current LiabilitesZX6.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 2B 4B 6B 8B

1

3. ZX6.DE Growth Analysis

3.1 Past

  • ZX6 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -543.62%.
  • ZX6 shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -29.42%.
  • Measured over the past years, ZX6 shows a small growth in Revenue. The Revenue has been growing by 2.50% on average per year.
EPS 1Y (TTM)-543.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-29.42%
Revenue growth 3Y2.5%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • ZX6 is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.41% yearly.
  • ZX6 is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -2.18% yearly.
EPS Next Y-1.36%
EPS Next 2Y5.62%
EPS Next 3Y6.98%
EPS Next 5Y8.41%
Revenue Next Year-15.56%
Revenue Next 2Y-5.73%
Revenue Next 3Y-4.09%
Revenue Next 5Y-2.18%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ZX6.DE Yearly Revenue VS EstimatesZX6.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2B 4B 6B 8B 10B
ZX6.DE Yearly EPS VS EstimatesZX6.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2 4 6

3

4. ZX6.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ZX6. In the last year negative earnings were reported.
  • Based on the Price/Forward Earnings ratio of 16.51, the valuation of ZX6 can be described as correct.
  • 62.32% of the companies in the same industry are more expensive than ZX6, based on the Price/Forward Earnings ratio.
  • ZX6 is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.84, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 16.51
ZX6.DE Price Earnings VS Forward Price EarningsZX6.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

  • ZX6's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ZX6 is cheaper than 65.22% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ZX6 indicates a somewhat cheap valuation: ZX6 is cheaper than 71.01% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 20.38
EV/EBITDA 8.98
ZX6.DE Per share dataZX6.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.62%
EPS Next 3Y6.98%

5

5. ZX6.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.12%, ZX6 is a good candidate for dividend investing.
  • ZX6's Dividend Yield is rather good when compared to the industry average which is at 2.35. ZX6 pays more dividend than 82.61% of the companies in the same industry.
  • ZX6's Dividend Yield is rather good when compared to the S&P500 average which is at 1.88.
Industry RankSector Rank
Dividend Yield 4.12%

5.2 History

Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A
ZX6.DE Yearly Dividends per shareZX6.DE Yearly Dividends per shareYearly Dividends per share 2026 0.2 0.4 0.6 0.8

5.3 Sustainability

  • ZX6 has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-66.23%
EPS Next 2Y5.62%
EPS Next 3Y6.98%
ZX6.DE Yearly Income VS Free CF VS DividendZX6.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 2025 0 1B -1B 2B

ZX6.DE Fundamentals: All Metrics, Ratios and Statistics

DSM-FIRMENICH AG

FRA:ZX6 (4/2/2026, 7:00:00 PM)

61.22

+0.32 (+0.53%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-12
Earnings (Next)05-06
Inst Owners33.03%
Inst Owner ChangeN/A
Ins Owners9.49%
Ins Owner ChangeN/A
Market Cap15.53B
Revenue(TTM)9.03B
Net Income(TTM)-1.08B
Analysts77.42
Price Target88.44 (44.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.12%
Yearly Dividend2.78
Dividend Growth(5Y)N/A
DP-66.23%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-14.84%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-1.91%
EPS NY rev (3m)-3.77%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-8.44%
Revenue NY rev (3m)-16.18%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 16.51
P/S 1.72
P/FCF 20.38
P/OCF 9.77
P/B 0.73
P/tB 3.24
EV/EBITDA 8.98
EPS(TTM)-4.17
EYN/A
EPS(NY)3.71
Fwd EY6.06%
FCF(TTM)3
FCFY4.91%
OCF(TTM)6.27
OCFY10.24%
SpS35.62
BVpS84.19
TBVpS18.88
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.34%
ROE -5.06%
ROCE 2.31%
ROIC 1.67%
ROICexc 1.86%
ROICexgc 5.1%
OM 7.39%
PM (TTM) N/A
GM 39.07%
FCFM 8.43%
ROA(3y)1.09%
ROA(5y)N/A
ROE(3y)1.5%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-6.79%
ROICexgc growth 5YN/A
ROICexc growth 3Y-20.59%
ROICexc growth 5YN/A
OM growth 3Y-2.63%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.82%
GM growth 5YN/A
F-Score5
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 7.12
Debt/EBITDA 2.58
Cap/Depr 61.7%
Cap/Sales 9.17%
Interest Coverage 8.79
Cash Conversion 79.1%
Profit Quality N/A
Current Ratio 2.69
Quick Ratio 1.74
Altman-Z 1.88
F-Score5
WACC3.96%
ROIC/WACC0.42
Cap/Depr(3y)43.41%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.95%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-543.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-1.36%
EPS Next 2Y5.62%
EPS Next 3Y6.98%
EPS Next 5Y8.41%
Revenue 1Y (TTM)-29.42%
Revenue growth 3Y2.5%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-15.56%
Revenue Next 2Y-5.73%
Revenue Next 3Y-4.09%
Revenue Next 5Y-2.18%
EBIT growth 1Y19.29%
EBIT growth 3Y-0.2%
EBIT growth 5YN/A
EBIT Next Year58.69%
EBIT Next 3Y20.18%
EBIT Next 5Y14.78%
FCF growth 1Y1.06%
FCF growth 3Y27.8%
FCF growth 5YN/A
OCF growth 1Y9.5%
OCF growth 3Y14.11%
OCF growth 5YN/A

DSM-FIRMENICH AG / ZX6.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of DSM-FIRMENICH AG (ZX6.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ZX6.DE.


What is the valuation status of DSM-FIRMENICH AG (ZX6.DE) stock?

ChartMill assigns a valuation rating of 3 / 10 to DSM-FIRMENICH AG (ZX6.DE). This can be considered as Overvalued.


What is the profitability of ZX6 stock?

DSM-FIRMENICH AG (ZX6.DE) has a profitability rating of 2 / 10.


What is the expected EPS growth for DSM-FIRMENICH AG (ZX6.DE) stock?

The Earnings per Share (EPS) of DSM-FIRMENICH AG (ZX6.DE) is expected to decline by -1.36% in the next year.


Is the dividend of DSM-FIRMENICH AG sustainable?

The dividend rating of DSM-FIRMENICH AG (ZX6.DE) is 5 / 10 and the dividend payout ratio is -66.23%.